The Roberson Lab
Research Lab Members Publications Lab News
Available Positions UAB & BHM Lab Life Support & Contact
ResearchLab MembersPublicationsLab News
The Roberson Lab
Available PositionsUAB & BHMLab LifeSupport & Contact
Alzheimer's disease risk gene BIN1 induces Tau-dependent network hyperexcitability
Alzheimer's disease risk gene BIN1 induces Tau-dependent network hyperexcitability

Alzheimer's disease risk gene BIN1 induces Tau-dependent network hyperexcitability

Voskobiynyk, Y., J.R. Roth, J.N. Cochran, T. Rush, N.V.N. Carullo, J.S. Mesina, M. Waqas, R.M. Vollmer, J.J. Day, L.L. McMahon, and E.D. Roberson. (2020). Alzheimer’s disease risk gene BIN1 induces Tau-dependent network hyperexcitability. eLife 10.7554/eLife.57354.

Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations

Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations

Arrant, A.E., J.R. Roth, N.R. Boyle, S.N. Kashyap, M.Q. Hoffmann, C.F. Murchison, E.M. Ramos, A.L. Nana, S. Spina, L.T. Grinberg, B.L. Miller, W.W. Seeley, and E.D. Roberson. (2019). Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations. Acta Neuropathol. Commun. 7:218

A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity

A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity

Rush, T., J.R. Roth, S.J. Thompson, Adam R. Aldaher, J.N. Cochran, and E.D. Roberson. (2019). A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity. Neurobiol. Dis. doi: 10.1016/j.nbd.2019.104668.

Neurodegenerative Disease–Associated Variants in TREM2 Destabilize the Apical Ligand-Binding Region of the Immunoglobulin Domain

Neurodegenerative Disease–Associated Variants in TREM2 Destabilize the Apical Ligand-Binding Region of the Immunoglobulin Domain

Dean, H.B., E.D. Roberson, and Y. Song. (2019). Neurodegenerative Disease–Associated Variants in TREM2 Destabilize the Apical Ligand-Binding Region of the Immunoglobulin Domain. Front. Neurol. DOI: 10.3389/fneur.2019.01252.

Progranulin gene therapy improves lysosomal function and microglial pathology associated with frontotemporal dementia and neuronal ceroid lipofuscinosis

Progranulin gene therapy improves lysosomal function and microglial pathology associated with frontotemporal dementia and neuronal ceroid lipofuscinosis

A.E. Arrant, V.C. Onyilo, D.E. Unger, and E.D. Roberson. (2018). J. Neurosci. 38:2341–2358.

Commentary in Nat. Rev. Neurology

Restoring neuronal progranulin reverses deficits in a frontotemporal dementia model

Restoring neuronal progranulin reverses deficits in a frontotemporal dementia model

A.E. Arrant, A.J. Filiano, D.E. Unger, A.H. Young, and E.D. Roberson. (2017). Brain 140:1447–1465.

Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer’s disease

Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer’s disease

Hall, A.M., B.T. Throesch, S.C. Buckingham, S.J. Markwardt, Y. Peng, Q. Wang, D.A. Hoffman, and E.D. Roberson. (2015). Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer’s disease. J. Neurosci. 35:6221–6230

Tau-mediated NMDA receptor impairment underlies dysfunction of a selectively vulnerable network in a mouse model of frontotemporal dementia

Tau-mediated NMDA receptor impairment underlies dysfunction of a selectively vulnerable network in a mouse model of frontotemporal dementia

Warmus, B.A., D.R. Sekar, E. McCutchen, G.D. Schellenberg, R.C. Roberts, L.L. McMahon, and E.D. Roberson. (2014). J. Neurosci. 34:16482–16495.

Reducing endogenous tau ameliorates Aβ-induced deficits in an Alzheimer’s disease mouse model

Reducing endogenous tau ameliorates Aβ-induced deficits in an Alzheimer’s disease mouse model

Roberson, E.D., K. Scearce-Levie, J.J. Palop, F. Yan, I. Cheng, T. Wu, H. Gerstein, G.-Q. Yu, and L. Mucke. (2007). Science 316:750–754.

Commentary in N. Engl. J. Med.

Commentary in Nat. Rev. Neurosci.

Commentary on AlzForum

1 2 3 4 5 6 7 8 9
Previous Next
Alzheimer's disease risk gene BIN1 induces Tau-dependent network hyperexcitability
Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations
A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity
Neurodegenerative Disease–Associated Variants in TREM2 Destabilize the Apical Ligand-Binding Region of the Immunoglobulin Domain
Progranulin gene therapy improves lysosomal function and microglial pathology associated with frontotemporal dementia and neuronal ceroid lipofuscinosis
Restoring neuronal progranulin reverses deficits in a frontotemporal dementia model
Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer’s disease
Tau-mediated NMDA receptor impairment underlies dysfunction of a selectively vulnerable network in a mouse model of frontotemporal dementia
Reducing endogenous tau ameliorates Aβ-induced deficits in an Alzheimer’s disease mouse model
Contact Us